Alcaligenes xylosoxidans keratitis post penetrating keratoplasty in a rigid gas permeable lens wearer

We report a case of Alcaligenes xylosoxidans keratitis following penetrating keratoplasty in a rigid gas permeable (RGP) lens wearer. A 61 year old RGP lens wearer with a history of nonresponsive keratitis of the right eye which involved the graft margin was referred to us for treatment. Corneal cul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The CLAO journal 1998-10, Vol.24 (4), p.239-241
Hauptverfasser: LIN, A, DRIEBE, W. T, POLACK, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 241
container_issue 4
container_start_page 239
container_title The CLAO journal
container_volume 24
creator LIN, A
DRIEBE, W. T
POLACK, P
description We report a case of Alcaligenes xylosoxidans keratitis following penetrating keratoplasty in a rigid gas permeable (RGP) lens wearer. A 61 year old RGP lens wearer with a history of nonresponsive keratitis of the right eye which involved the graft margin was referred to us for treatment. Corneal cultures revealed growth of a gram-negative rod on the fifth day and the organism was subsequently identified as Alcaligenes xylosoxidans, which was resistant to most antibiotics and sensitive only to Bactrim, Timentin, and imipenem. Clinical improvement was observed within 24 hours after treatment with the use of topical i.v. Bactrim and topical i.v. Timentin 2% alternating every 30 minutes. Complete resolution of the infection with mild scarring was observed 6 weeks after treatment. Alcaligenes xylosoxidans is a potential cause of bacterial keratitis which should be considered in cases of nonresponsive gram-negative keratitis. The addition of topical Bactrim or Timentin may need to be considered in such cases.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70012902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70012902</sourcerecordid><originalsourceid>FETCH-LOGICAL-p150t-cc2c6f845d1b668156907fead960c232c91dd6982d1ceb71eec16baba9c5701a3</originalsourceid><addsrcrecordid>eNo9kE1LxDAURYMo4zj6E4QsxF3hpbVpshwGv2DAja7La_Jaopm2Jh2c-fdGpshbXHjncBf3jC1FWagMhBLnbAlVUWRKQ37JrmL8BMjTVQu20AoAZLlktPYGveuop8gPRz_E4eAs9pF_UcDJTS7ycYgTH5Mx_X367oSG0WOcjtz1HHlwnbO8wyRT2BE2nrin1PJDGChcs4sWfaSbOVfs4-nxffOSbd-eXzfrbTaKEqbMmNzIVj2UVjRSKlFKDVVLaLUEkxe50cJaqVVuhaGmEkRGyAYb1KasQGCxYven3jEM33uKU71z0ZD32NOwj3UFIPI0RxJvZ3Hf7MjWY3A7DMd63iXxu5ljTPu0AXvj4r8mSgW6kMUvduRuyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70012902</pqid></control><display><type>article</type><title>Alcaligenes xylosoxidans keratitis post penetrating keratoplasty in a rigid gas permeable lens wearer</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>LIN, A ; DRIEBE, W. T ; POLACK, P</creator><creatorcontrib>LIN, A ; DRIEBE, W. T ; POLACK, P</creatorcontrib><description>We report a case of Alcaligenes xylosoxidans keratitis following penetrating keratoplasty in a rigid gas permeable (RGP) lens wearer. A 61 year old RGP lens wearer with a history of nonresponsive keratitis of the right eye which involved the graft margin was referred to us for treatment. Corneal cultures revealed growth of a gram-negative rod on the fifth day and the organism was subsequently identified as Alcaligenes xylosoxidans, which was resistant to most antibiotics and sensitive only to Bactrim, Timentin, and imipenem. Clinical improvement was observed within 24 hours after treatment with the use of topical i.v. Bactrim and topical i.v. Timentin 2% alternating every 30 minutes. Complete resolution of the infection with mild scarring was observed 6 weeks after treatment. Alcaligenes xylosoxidans is a potential cause of bacterial keratitis which should be considered in cases of nonresponsive gram-negative keratitis. The addition of topical Bactrim or Timentin may need to be considered in such cases.</description><identifier>ISSN: 0733-8902</identifier><identifier>EISSN: 1538-0181</identifier><identifier>PMID: 9800065</identifier><identifier>CODEN: CLAJEU</identifier><language>eng</language><publisher>New York, NY: Kellner/McCaffery</publisher><subject><![CDATA[Administration, Topical ; Alcaligenes - isolation & purification ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - therapeutic use ; Bacterial Infections - drug therapy ; Bacterial Infections - etiology ; Bacterial Infections - microbiology ; Biological and medical sciences ; Clavulanic Acids - administration & dosage ; Clavulanic Acids - therapeutic use ; Contact Lenses ; Cornea - microbiology ; Drug Therapy, Combination - administration & dosage ; Drug Therapy, Combination - therapeutic use ; Gases ; Humans ; Keratitis - etiology ; Keratitis - microbiology ; Keratoplasty, Penetrating ; Male ; Medical sciences ; Middle Aged ; Permeability ; Postoperative Complications ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the eye and orbit ; Ticarcillin - administration & dosage ; Ticarcillin - therapeutic use ; Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage ; Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use]]></subject><ispartof>The CLAO journal, 1998-10, Vol.24 (4), p.239-241</ispartof><rights>1999 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1580936$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9800065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LIN, A</creatorcontrib><creatorcontrib>DRIEBE, W. T</creatorcontrib><creatorcontrib>POLACK, P</creatorcontrib><title>Alcaligenes xylosoxidans keratitis post penetrating keratoplasty in a rigid gas permeable lens wearer</title><title>The CLAO journal</title><addtitle>CLAO J</addtitle><description>We report a case of Alcaligenes xylosoxidans keratitis following penetrating keratoplasty in a rigid gas permeable (RGP) lens wearer. A 61 year old RGP lens wearer with a history of nonresponsive keratitis of the right eye which involved the graft margin was referred to us for treatment. Corneal cultures revealed growth of a gram-negative rod on the fifth day and the organism was subsequently identified as Alcaligenes xylosoxidans, which was resistant to most antibiotics and sensitive only to Bactrim, Timentin, and imipenem. Clinical improvement was observed within 24 hours after treatment with the use of topical i.v. Bactrim and topical i.v. Timentin 2% alternating every 30 minutes. Complete resolution of the infection with mild scarring was observed 6 weeks after treatment. Alcaligenes xylosoxidans is a potential cause of bacterial keratitis which should be considered in cases of nonresponsive gram-negative keratitis. The addition of topical Bactrim or Timentin may need to be considered in such cases.</description><subject>Administration, Topical</subject><subject>Alcaligenes - isolation &amp; purification</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - etiology</subject><subject>Bacterial Infections - microbiology</subject><subject>Biological and medical sciences</subject><subject>Clavulanic Acids - administration &amp; dosage</subject><subject>Clavulanic Acids - therapeutic use</subject><subject>Contact Lenses</subject><subject>Cornea - microbiology</subject><subject>Drug Therapy, Combination - administration &amp; dosage</subject><subject>Drug Therapy, Combination - therapeutic use</subject><subject>Gases</subject><subject>Humans</subject><subject>Keratitis - etiology</subject><subject>Keratitis - microbiology</subject><subject>Keratoplasty, Penetrating</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Permeability</subject><subject>Postoperative Complications</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the eye and orbit</subject><subject>Ticarcillin - administration &amp; dosage</subject><subject>Ticarcillin - therapeutic use</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination - administration &amp; dosage</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use</subject><issn>0733-8902</issn><issn>1538-0181</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LxDAURYMo4zj6E4QsxF3hpbVpshwGv2DAja7La_Jaopm2Jh2c-fdGpshbXHjncBf3jC1FWagMhBLnbAlVUWRKQ37JrmL8BMjTVQu20AoAZLlktPYGveuop8gPRz_E4eAs9pF_UcDJTS7ycYgTH5Mx_X367oSG0WOcjtz1HHlwnbO8wyRT2BE2nrin1PJDGChcs4sWfaSbOVfs4-nxffOSbd-eXzfrbTaKEqbMmNzIVj2UVjRSKlFKDVVLaLUEkxe50cJaqVVuhaGmEkRGyAYb1KasQGCxYven3jEM33uKU71z0ZD32NOwj3UFIPI0RxJvZ3Hf7MjWY3A7DMd63iXxu5ljTPu0AXvj4r8mSgW6kMUvduRuyw</recordid><startdate>199810</startdate><enddate>199810</enddate><creator>LIN, A</creator><creator>DRIEBE, W. T</creator><creator>POLACK, P</creator><general>Kellner/McCaffery</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199810</creationdate><title>Alcaligenes xylosoxidans keratitis post penetrating keratoplasty in a rigid gas permeable lens wearer</title><author>LIN, A ; DRIEBE, W. T ; POLACK, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p150t-cc2c6f845d1b668156907fead960c232c91dd6982d1ceb71eec16baba9c5701a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Administration, Topical</topic><topic>Alcaligenes - isolation &amp; purification</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - etiology</topic><topic>Bacterial Infections - microbiology</topic><topic>Biological and medical sciences</topic><topic>Clavulanic Acids - administration &amp; dosage</topic><topic>Clavulanic Acids - therapeutic use</topic><topic>Contact Lenses</topic><topic>Cornea - microbiology</topic><topic>Drug Therapy, Combination - administration &amp; dosage</topic><topic>Drug Therapy, Combination - therapeutic use</topic><topic>Gases</topic><topic>Humans</topic><topic>Keratitis - etiology</topic><topic>Keratitis - microbiology</topic><topic>Keratoplasty, Penetrating</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Permeability</topic><topic>Postoperative Complications</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the eye and orbit</topic><topic>Ticarcillin - administration &amp; dosage</topic><topic>Ticarcillin - therapeutic use</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination - administration &amp; dosage</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use</topic><toplevel>online_resources</toplevel><creatorcontrib>LIN, A</creatorcontrib><creatorcontrib>DRIEBE, W. T</creatorcontrib><creatorcontrib>POLACK, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The CLAO journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LIN, A</au><au>DRIEBE, W. T</au><au>POLACK, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alcaligenes xylosoxidans keratitis post penetrating keratoplasty in a rigid gas permeable lens wearer</atitle><jtitle>The CLAO journal</jtitle><addtitle>CLAO J</addtitle><date>1998-10</date><risdate>1998</risdate><volume>24</volume><issue>4</issue><spage>239</spage><epage>241</epage><pages>239-241</pages><issn>0733-8902</issn><eissn>1538-0181</eissn><coden>CLAJEU</coden><abstract>We report a case of Alcaligenes xylosoxidans keratitis following penetrating keratoplasty in a rigid gas permeable (RGP) lens wearer. A 61 year old RGP lens wearer with a history of nonresponsive keratitis of the right eye which involved the graft margin was referred to us for treatment. Corneal cultures revealed growth of a gram-negative rod on the fifth day and the organism was subsequently identified as Alcaligenes xylosoxidans, which was resistant to most antibiotics and sensitive only to Bactrim, Timentin, and imipenem. Clinical improvement was observed within 24 hours after treatment with the use of topical i.v. Bactrim and topical i.v. Timentin 2% alternating every 30 minutes. Complete resolution of the infection with mild scarring was observed 6 weeks after treatment. Alcaligenes xylosoxidans is a potential cause of bacterial keratitis which should be considered in cases of nonresponsive gram-negative keratitis. The addition of topical Bactrim or Timentin may need to be considered in such cases.</abstract><cop>New York, NY</cop><pub>Kellner/McCaffery</pub><pmid>9800065</pmid><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0733-8902
ispartof The CLAO journal, 1998-10, Vol.24 (4), p.239-241
issn 0733-8902
1538-0181
language eng
recordid cdi_proquest_miscellaneous_70012902
source MEDLINE; Journals@Ovid Complete
subjects Administration, Topical
Alcaligenes - isolation & purification
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
Bacterial Infections - drug therapy
Bacterial Infections - etiology
Bacterial Infections - microbiology
Biological and medical sciences
Clavulanic Acids - administration & dosage
Clavulanic Acids - therapeutic use
Contact Lenses
Cornea - microbiology
Drug Therapy, Combination - administration & dosage
Drug Therapy, Combination - therapeutic use
Gases
Humans
Keratitis - etiology
Keratitis - microbiology
Keratoplasty, Penetrating
Male
Medical sciences
Middle Aged
Permeability
Postoperative Complications
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the eye and orbit
Ticarcillin - administration & dosage
Ticarcillin - therapeutic use
Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage
Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
title Alcaligenes xylosoxidans keratitis post penetrating keratoplasty in a rigid gas permeable lens wearer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A54%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alcaligenes%20xylosoxidans%20keratitis%20post%20penetrating%20keratoplasty%20in%20a%20rigid%20gas%20permeable%20lens%20wearer&rft.jtitle=The%20CLAO%20journal&rft.au=LIN,%20A&rft.date=1998-10&rft.volume=24&rft.issue=4&rft.spage=239&rft.epage=241&rft.pages=239-241&rft.issn=0733-8902&rft.eissn=1538-0181&rft.coden=CLAJEU&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E70012902%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70012902&rft_id=info:pmid/9800065&rfr_iscdi=true